Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019;141(3):188-200.
doi: 10.1159/000495726. Epub 2019 Jan 9.

Mean Corpuscular Volume and Mortality in Incident Hemodialysis Patients

Affiliations

Mean Corpuscular Volume and Mortality in Incident Hemodialysis Patients

Alissa Dratch et al. Nephron. 2019.

Abstract

Background/aims: Anemia is common in patients with advanced chronic kidney disease (CKD). A proportion of patients present with macrocytic anemia, manifested by elevated mean corpuscular volume (MCV), which has been associated with worse outcomes in CKD patients. However, it is unknown whether elevated MCV is associated with higher mortality risk in incident hemodialysis (HD) patients.

Methods: This retrospective observational cohort study examined all-cause, cardiovascular, and infectious mortality associations with both baseline and time-varying MCV in 109,501 incident HD patients using Cox proportional hazards models with 3 levels of hierarchical multivariable adjustment. Odds ratios of high versus low baseline MCV were evaluated using logistic regression.

Results: The mean age of patients was 65 ± 15 (standard deviation) years and the cohort was 44% female, 58% diabetic, and 31% African American. Higher MCV was associated with older age, female sex, non-Hispanic White race-ethnicity, alcohol consumption, and having a decreased albumin or protein intake. Patients with higher MCV levels (> 98 fL) had a higher all-cause, cardiovascular, and infectious mortality risk in both baseline and time varying models, and across all levels of adjustment. In the fully adjusted models, compared to a reference of MCV 92-< 94 fL, patients with a baseline MCV > 100+ fL had a 28% higher risk of all-cause mortality (hazard ratio [HR] 1.28, 95% CI 1.22-1.34), 27% higher risk of cardiovascular mortality (HR 1.27, 95% CI 1.18-1.36), and 18% higher risk of infectious mortality (HR 1.18, 95% CI 1.02-1.38). Associations of higher MCV with these adverse outcomes persisted across all examined subgroups of clinical characteristics.

Conclusions: Higher MCV was associated with higher all-cause, cardiovascular, and infectious mortality in HD patients. Further investigation is necessary to understand the underlying nature of the observed association.

Keywords: Anemia; Incident hemodialysis; Mean corpuscular volume; Mortality.

PubMed Disclaimer

Conflict of interest statement

Potential Conflict of Interest: KKZ has received honoraria and/or support from Abbott, Abbvie, Alexion, Amgen, American Society of Nephrology, Astra-Zeneca, AVEO, Chugai, DaVita, Fresenius, Genetech, Haymarket Media, Hospira, Kabi, Keryx, National Institutes of Health, National Kidney Foundation, Relypsa, Resverlogix, Sanofi, Shire, Vifor, ZS-Pharma. CPK has received honoraria from Sanofi-Aventis, Relypsa and ZS Pharma.

Figures

Figure 1.
Figure 1.
Baseline all-cause (A) and cardiovascular (B) mortality and time-varying all-cause (C) and cardiovascular (D) mortality hazard ratios (and 95%CI error bars) by MCV levels across three levels of multivariable adjustment.
Figure 2.
Figure 2.
Subgroup analysis of all-cause (A and B) and cardiovascular (C and D) mortality hazard ratios (and 95%CI error bars) of high MCV (MCV≥93 fl) vs low MCV (MCV <93 fl) across three levels of multivariable adjustment. Abbreviations: BMI, body mass index; CHF, congestive heart failure; nPCR, normalized protein catabolic rate; RDW, red cell distribution width; TIBC, total iron binding capacity; iv, intravenous; B12, vitamin B12

Similar articles

Cited by

References

    1. Stauffer ME, Fan T: Prevalence of anemia in chronic kidney disease in the United States. PLoS One 2014;9:e84943. - PMC - PubMed
    1. Sarma PR: Red Cell Indices; in Walker HK, Hall WD, Hurst JW (eds): Clinical Methods: The History, Physical, and Laboratory Examinations; Boston, 1990 - PubMed
    1. Suega K, Bakta M, Dharmayudha TG, Lukman JS, Suwitra K: Profile of anemia in chronic renal failure patients: comparison between predialyzed and dialyzed patients at the Division of Nephrology, Department of Internal Medicine, Sanglah Hospital, Denpasar, Bali, Indonesia. Acta Med Indones 2005;37:190–194. - PubMed
    1. Eschbach JW, Adamson JW: Recombinant human erythropoietin: implications for nephrology. Am J Kidney Dis 1988;11:203–209. - PubMed
    1. Ly J, Marticorena R, Donnelly S: Red blood cell survival in chronic renal failure. AAm J Kidney Dis 2004;44:715–719. - PubMed

Publication types